RANI(Rani Therapeutics Holdings, Inc.) · 财务报表

RANI(Rani Therapeutics Holdings, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$2.72M$0$0$1.03M$1.63M
毛利润—————
营业利润−$51.60M−$63.45M−$66.10M−$53.31M−$38.31M
净利润−$8.33M−$30.59M−$33.97M−$30.02M−$29.67M
经营现金流−$32.24M−$46.52M−$51.24M−$35.50M−$18.71M
自由现金流−$32.75M−$48.13M−$52.47M−$35.76M−$18.80M
摊薄每股收益$-0.43$-1.28$-1.33$-1.05$-0.45

Rani Therapeutics Holdings, Inc. RANI